Nestle Divests Mainstream Supplements Business for $1 Billion

Swiss food giant Nestle has agreed to sell its mainstream nutritional supplements business for approximately $1 billion. According to Reuters, this move is part of the company's strategy to restructure its portfolio and focus on higher growth potential. The sale marks a significant stage in Nestle's review of its health science assets. Under the agreement, the division encompassing vitamins, minerals, and supplement products, along with its globally recognized brands, will be transferred to a new owner. This transaction is seen as an effort by Nestle to rebalance its investments in consumer health products made in recent years. The company plans to use the proceeds from the sale to reduce debt and invest in core business areas. Experts note that this divestiture could enhance operational efficiency by simplifying Nestle's portfolio. Upon completion of the sale, the company's focus within the health science segment is expected to shift toward more innovative, higher-margin products. This move also holds strategic importance in adapting to competitive conditions in the global supplements market. Nestle's management anticipates the deal will close within 2025, pending regulatory approvals. The company has stated it will work in coordination with relevant parties during this process to ensure uninterrupted operations. As financial details become clearer, investors are expected to gain a more defined picture of the company's future growth strategy. This is not investment advice.